The first one, related to Motion No. 18, is moxifloxacin hydrochloride tablet, 400 mg, and intravenous solution, 400 mg/250 ml.
Le premier, dont il est question dans la motion n 18 est le chlorhydrate de moxifloxacine comprimé, 400 mg; solution intraveineuse, 400 mg/250 ml.